Kolexia
Sefrioui David Gastro-entérologie
Sefrioui David
Gastro-entérologie
Hôpital Charles Nicolle
Rouen, France
113 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Instabilité des microsatellites Carcinomes Tumeurs du côlon Adénocarcinome Tumeurs du sein Cellules tumorales circulantes Tumeurs du foie

Collaborateurs

Voir plus
Di Fiore Frederic
Di Fiore Frederic
Hôpital Charles Nicolle, Rouen, France
Michel Pierre
Michel Pierre
Hôpital Charles Nicolle, Rouen, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Clatot Florian
Clatot Florian
Centre Henri-Becquerel, Rouen, France

Industries

Voir plus
Servier
12 collaboration(s)
Dernière en 2023
Ipsen
9 collaboration(s)
Dernière en 2021
CanceroDigest
3 collaboration(s)
Dernière en 2022
Bayer
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PROACTIF: A Prospective, Post Approval, Multiple Centre, Open-Label, Non-Interventional, Registry Study to Evaluate Effectiveness of TheraSphere® in Clinical Practice in France
Essai Clinique (Boston Scientific)   21 février 2024
COBRAF: A Study to Collect Patients, Medical, and Biological Data From Patients Being Treated for Metastatic Colorectal Cancer With a Specific Genetic Mutation: BRAFV600E
Essai Clinique (Pierre Fabre)   07 novembre 2023
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
International journal of cancer   05 juillet 2023
Prognostic value of Lynch syndrome, BRAF , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts.
Cancer medicine   16 juin 2023
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer.
Frontiers in oncology   10 novembre 2022
365P Prognostic value of Lynch syndrome, BRAFV600E and RAS mutation status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of the national Dutch and French cohorts
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Colorectal cancer chemoprevention: is aspirin still in the game?
Cancer biology & therapy   02 août 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.
2022 ASCO Annual Meeting I   02 juin 2022